Filter Results
:
(693)
Show Results For
- All HBS Web (693)
- Faculty Publications (209)
Show Results For
- All HBS Web (693)
- Faculty Publications (209)
- Web
Drug & Alcohol Policy | About
Drug & Alcohol Policy Overview of HBS Substance Abuse Policies and Procedures Harvard Business School’s policy on drugs and alcohol—adapted from and in accordance with other...
View Details
- Article
Policies to Influence Perceptions about COVID-19 Risk: The Case of Maps
By: Claudia Engel, Jonathan Rodden and Marco Tabellini
Choropleth disease maps have become an important tool for informing the public about the risks posed by COVID-19. In a survey conducted in the U.S. state of Georgia in June 2020, we randomly assigned respondents to view either of two maps. The first one reported...
View Details
Engel, Claudia, Jonathan Rodden, and Marco Tabellini. "Policies to Influence Perceptions about COVID-19 Risk: The Case of Maps." Science Advances 8, no. 11 (March 18, 2022).
- 2021
- Working Paper
How Much Should We Trust Staggered Difference-In-Differences Estimates?
By: Andrew C. Baker, David F. Larcker and Charles C.Y. Wang
Difference-in-differences analysis with staggered treatment timing is frequently used to assess the impact of policy changes on corporate outcomes in academic research. However, recent advances in econometric theory show that such designs are likely to be biased in the...
View Details
Keywords:
Difference In Differences;
Staggered Difference-in-differences Designs;
Generalized Difference-in-differences;
Dynamic Treatment Effects;
Mathematical Methods
Baker, Andrew C., David F. Larcker, and Charles C.Y. Wang. "How Much Should We Trust Staggered Difference-In-Differences Estimates?" European Corporate Governance Institute Finance Working Paper, No. 736/2021, February 2021. (Harvard Business School Working Paper, No. 21-112, April 2021.)
- Web
2.3.1 Drug & Alcohol Policy - MBA
treatment or counseling program; loss of room reservation privileges; involuntary withdrawal or suspension; termination of employment; and/or referral for prosecution. Amnesty Policy Any student may bring an...
View Details
- 2017
- Casebook
Public Health Preparedness: Case Studies in Policy and Management
By: Arnold M. Howitt, Dutch Leonard and David W. Giles
This book provides detailed accounts of a range of public health emergencies. Topics range from natural disasters, to infectious diseases, to pandemics, and more. With chapters on Superstorm Sandy, H1N1, the Ebola virus, and bioterrorism, these cases cover major areas...
View Details
Keywords:
Health Care and Treatment;
Health Pandemics;
Natural Disasters;
Safety;
Public Sector;
Policy;
Management
Howitt, Arnold M., Dutch Leonard and David W. Giles, eds. Public Health Preparedness: Case Studies in Policy and Management. Washington, DC: American Public Health Association, 2017.
- 31 May 2012
- Working Paper Summaries
Conflict Policy and Advertising Agency-Client Relations: The Problem of Competing Clients Sharing a Common Agency
- 2012
- Working Paper
Conflict Policy and Advertising Agency-Client Relations: The Problem of Competing Clients Sharing a Common Agency
By: Alvin J. Silk
What restrictions should be placed on advertising agencies with respect to serving accounts or clients that are competitors of one another in order to avoid conflicts in interest? In recent decades, the advertising and marketing services industry has undergone a number...
View Details
Keywords:
Advertising;
Service Delivery;
Competition;
Conflict of Interests;
Policy;
Practice;
Advertising Industry;
United States
Silk, Alvin J. "Conflict Policy and Advertising Agency-Client Relations: The Problem of Competing Clients Sharing a Common Agency." Marketing Science Institute Report, No. 12-104, May 2012.
- Article
How Much Should We Trust Staggered Difference-In-Differences Estimates?
By: Andrew C. Baker, David F. Larcker and Charles C.Y. Wang
We explain when and how staggered difference-in-differences regression estimators, commonly applied to assess the impact of policy changes, are biased. These biases are likely to be relevant for a large portion of research settings in finance, accounting, and law that...
View Details
Keywords:
Difference In Differences;
Staggered Difference-in-differences Designs;
Generalized Difference-in-differences;
Dynamic Treatment Effects;
Mathematical Methods
Baker, Andrew C., David F. Larcker, and Charles C.Y. Wang. "How Much Should We Trust Staggered Difference-In-Differences Estimates?" Journal of Financial Economics 144, no. 2 (May 2022): 370–395. (Editor's Choice, May 2022; Jensen Prize, First Place, June 2023.)
- Forthcoming
- Article
Doing More with Less: Overcoming Ineffective Long-Term Targeting Using Short-Term Signals
By: Ta-Wei Huang and Eva Ascarza
Firms are increasingly interested in developing targeted interventions for customers with the best response,
which requires identifying differences in customer sensitivity, typically through the conditional average treatment
effect (CATE) estimation. In theory, to...
View Details
Keywords:
Long-run Targeting;
Heterogeneous Treatment Effect;
Statistical Surrogacy;
Customer Churn;
Field Experiments;
Consumer Behavior;
Customer Focus and Relationships;
AI and Machine Learning;
Marketing Strategy
Huang, Ta-Wei, and Eva Ascarza. "Doing More with Less: Overcoming Ineffective Long-Term Targeting Using Short-Term Signals." Marketing Science (forthcoming). (Pre-published online March 6, 2024.)
- 2023
- Article
Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping
By: Robin van Kessel, Divya Srivastava, Ilias Kyriopoulos, Giovanni Monti, David Novillo-Ortiz, Ran Milman, Wojciech Wilhelm Zhang-Czabanowski, Greta Nasi, Ariel Dora Stern, George Wharton and Elias Mossialos
Background: The adoption of digital health care within health systems is determined by various factors, including pricing and reimbursement. The reimbursement landscape for digital health in Europe remains underresearched. Although various emergency reimbursement...
View Details
Keywords:
Technology Adoption;
Health Care and Treatment;
Cross-Cultural and Cross-Border Issues;
Price;
Health Industry;
Europe;
Israel
van Kessel, Robin, Divya Srivastava, Ilias Kyriopoulos, Giovanni Monti, David Novillo-Ortiz, Ran Milman, Wojciech Wilhelm Zhang-Czabanowski, Greta Nasi, Ariel Dora Stern, George Wharton, and Elias Mossialos. "Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping." e49003. JMIR mHealth and uHealth 11 (2023).
- 2022
- Working Paper
The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives
By: Ariel Dora Stern
For those who follow health and technology news, it is difficult to go more than a few days without reading about a compelling new application of Artificial Intelligence (AI) to health care. AI has myriad applications in medicine and its adjacent industries, with...
View Details
Keywords:
AI and Machine Learning;
Health Care and Treatment;
Governing Rules, Regulations, and Reforms;
Technological Innovation;
Medical Devices and Supplies Industry
Stern, Ariel Dora. "The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives." NBER Working Paper Series, No. 30639, December 2022.
- 2023
- Working Paper
Can Evidence-Based Information Shift Preferences Towards Trade Policy?
By: Laura Alfaro, Maggie X. Chen and Davin Chor
We investigate the role of evidence-based information in shaping individuals' preferences for trade policies through a series of survey experiments that contain randomized information treatments. Each treatment provides a concise statement of economics research...
View Details
Alfaro, Laura, Maggie X. Chen, and Davin Chor. "Can Evidence-Based Information Shift Preferences Towards Trade Policy?" Harvard Business School Working Paper, No. 22-062, March 2022. (Revised May 2023. NBER Working Paper Series, No. 31240, May 2023)
- Article
Trends and Predictors of Biomedical Research Quality, 1990–2015: A Meta-Research Study
By: Maryaline Catillon
Keywords:
Biomedical Research;
R&D;
Innovation;
Technology;
Drug Trials;
RCT;
Health;
Healthcare;
Health Care And Treatment;
Health Care Policy;
Innovation and Invention;
Innovation Strategy;
Research and Development;
Technological Innovation;
Health Industry;
Pharmaceutical Industry
Catillon, Maryaline. "Trends and Predictors of Biomedical Research Quality, 1990–2015: A Meta-Research Study." BMJ Open 9, no. 9 (September 2019).
- April 2018
- Article
The Power of Voice in Stimulating Morality: Eliciting Taxpayer Preferences Increases Tax Compliance
By: Cait Lamberton, Jan-Emmanuel De Neve and Michael I. Norton
Decisions about paying taxes represent one of the most common moral quandaries faced by citizens. In the
present research, we argue that taxpayer compliance can be raised by increasing “voice”: allowing taxpayers
to express non-binding preferences about the way their...
View Details
Keywords:
Morality;
Public Policy;
Ethics;
Moral Sensibility;
Taxation;
Policy;
Attitudes;
Governance Compliance
Lamberton, Cait, Jan-Emmanuel De Neve, and Michael I. Norton. "The Power of Voice in Stimulating Morality: Eliciting Taxpayer Preferences Increases Tax Compliance." Special Issue on Marketplace Morality. Journal of Consumer Psychology 28, no. 2 (April 2018): 310–328.
- January–February 2013
- Article
Fairness, Efficiency and Flexibility in Organ Allocation for Kidney Transplantation
By: Dimitris Bertsimas, Vivek F. Farias and Nikolaos Trichakis
We propose a scalable, data-driven method for designing national policies for the allocation of deceased donor kidneys to patients on a waiting list, in a fair and efficient way. We focus on policies that have the same form as the one currently used in the United...
View Details
Keywords:
Health Care Policy;
Healthcare;
Fairness;
Resource Allocation;
Policy;
Health Care and Treatment;
Medical Specialties;
Health Industry;
United States
Bertsimas, Dimitris, Vivek F. Farias, and Nikolaos Trichakis. "Fairness, Efficiency and Flexibility in Organ Allocation for Kidney Transplantation." Operations Research 61, no. 1 (January–February 2013): 73–87.
- September 2020
- Article
Medicaid Work Requirements in Arkansas: Two-Year Impacts on Coverage, Employment, and Affordability of Care
By: Benjamin D. Sommers, Lucy Chen, Robert J. Blendon, E. John Orav and Arnold M. Epstein
In June 2018 Arkansas became the first U.S. state to implement work requirements in Medicaid, requiring adults ages 30–49 to work twenty hours a week, participate in “community engagement” activities, or qualify for an exemption to maintain coverage. By April 2019,...
View Details
Keywords:
Medicaid;
Health Care Policy;
Health;
Health Care and Treatment;
Policy;
Insurance;
Health Industry;
Arkansas
Sommers, Benjamin D., Lucy Chen, Robert J. Blendon, E. John Orav, and Arnold M. Epstein. "Medicaid Work Requirements in Arkansas: Two-Year Impacts on Coverage, Employment, and Affordability of Care." Health Affairs 39, no. 9 (September 2020).
- September 2014 (Revised March 2016)
- Case
Mayo Clinic: The 2020 Initiative
By: Regina E. Herzlinger, Robert S. Huckman and Jenny Lesser
Describes the challenges facing Dr. John Noseworthy, President and CEO, in implementing a long-term strategy for the growth of the Mayo Clinic—a leading academic medical center with a reputation for excellence in tertiary and quaternary health care. The case highlights...
View Details
Keywords:
Health;
Health Care Industry;
Health Care Policy;
Health Care and Treatment;
Health Industry;
United States
Herzlinger, Regina E., Robert S. Huckman, and Jenny Lesser. "Mayo Clinic: The 2020 Initiative." Harvard Business School Case 615-027, September 2014. (Revised March 2016.)
- April 2010
- Case
Metabical: Pricing, Packaging, and Demand Forecasting Recommendations for a New Weight Loss Drug
By: John A. Quelch and Heather Beckham
Metabical is a new weight loss drug from Cambridge Sciences Pharmaceuticals intended for moderately overweight individuals. In anticipation of final FDA approval, the senior director of marketing, Barbara Printup, prepares for the product launch and must make several...
View Details
Keywords:
Return On Investment;
Forecasting;
Pricing Policies;
Demand Planning;
Marketing Strategy;
Price;
Consumer Behavior;
Investment Return;
Forecasting and Prediction;
Product Launch;
Planning;
Brands and Branding;
Pharmaceutical Industry
Quelch, John A., and Heather Beckham. "Metabical: Pricing, Packaging, and Demand Forecasting Recommendations for a New Weight Loss Drug." Harvard Business School Brief Case 104-183, April 2010.
- Article
The CMS New Rule on Ambulatory Surgical Centers Earns Only Partial Credit
By: Junaid Nabi and Robert S. Kaplan
The Centers of Medicare and Medicaid Services (CMS) recently announced that it will be removing more...
View Details
Keywords:
Ambulatory Care;
Payment Policy;
Health Care and Treatment;
Governing Rules, Regulations, and Reforms
Nabi, Junaid, and Robert S. Kaplan. "The CMS New Rule on Ambulatory Surgical Centers Earns Only Partial Credit." Health Affairs Blog (June 2, 2021).